Decipher Prostate
22-gene prostate-cancer genomic classifier used for prognostic and treatment-decision risk assessment.
- Developer
- Veracyte
- Intended use
- Risk Stratification
- Cancer scope
- Prostate cancer
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA expression
- Current version
- Current Decipher Prostate LDT as of 2026-09
- Evidence context
- 1 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.